Education
About Us
Working with TipRanks
Follow Us
LifeSpeak (TSE:LSPK)
TSX:LSPK
Top Page
LifeSpeak
(TSX:LSPK)
41Neutral
LifeSpeak (LSPK) vs. S&P 500 (SPY)
Market Cap
C$11.53M
Dividend YieldN/A
Average Volume (3M)8.59K
Price to Earnings (P/E)―
Beta (1Y)0.35
Revenue Growth-7.64%
EPS Growth12.36%
CountryCA
Employees130
SectorTechnology
Sector Strength46
IndustrySoftware - Application
Share Statistics
EPS (TTM)-0.45
Shares Outstanding59,136,130
10 Day Avg. Volume13,002
30 Day Avg. Volume8,591
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.32
Price to Cash Flow (P/CF)1.90
P/FCF Ratio0.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.23Price Target Upside15.00% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering3
LifeSpeak Business Overview & Revenue Model
Company DescriptionLifeSpeak (LSPK) is a leading provider in the digital wellness sector, offering a comprehensive platform designed to support mental health and well-being for organizations and their employees. The company's core products include on-demand expert-led educational content, digital tools, and resources that cover a range of topics such as mental health, stress management, nutrition, and physical fitness. LifeSpeak's platform is accessible 24/7, allowing users to engage with content at their convenience, fostering a healthier workplace environment.
How the Company Makes MoneyLifeSpeak makes money primarily through a subscription-based revenue model. Organizations, ranging from small businesses to large enterprises, subscribe to LifeSpeak's platform, paying a recurring fee to provide their employees with access to the company's extensive library of wellness resources. These subscriptions can be customized based on the number of employees and specific content needs. Additionally, LifeSpeak collaborates with various partners, including employee assistance programs (EAPs) and health insurance providers, to extend its market reach and enhance its service offerings. These partnerships can contribute to revenue through joint offerings and bundled services.
LifeSpeak Financial Statement Overview
Summary
LifeSpeak faces significant financial challenges, including declining revenues, sustained net losses, and a highly leveraged balance sheet. While the company generates positive operating cash flow, its overall financial health is hindered by high debt and negative equity, posing risks for future growth and stability.Income Statement
LifeSpeak's revenue has shown volatility, with a decline from 2023 to 2024 following a previous growth trend. The gross profit margin remains high, indicating effective cost management. However, persistent net losses and negative EBIT and EBITDA margins reveal ongoing profitability challenges.45
Neutral
Balance Sheet
The balance sheet reflects financial instability, with negative stockholders' equity and high debt levels leading to an unfavorable debt-to-equity ratio. The company's equity ratio is also negative, highlighting the risks associated with its leveraged position.30
Negative
Cash Flow
Operating cash flow is positive, demonstrating some operational efficiency. However, the free cash flow growth has been inconsistent, and the company faces challenges in converting income into cash due to negative net income.50
Neutral
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 48.40M | 52.41M | 47.37M | 23.27M | 10.08M |
| Gross Profit | ||||
| 42.89M | 47.02M | 42.60M | 20.92M | 9.07M |
| EBIT | ||||
| 343.29K | -11.67M | -21.82M | -6.40M | 1.94M |
| EBITDA | ||||
| -5.43M | -5.39M | -30.12M | -25.33M | 392.75K |
| Net Income Common Stockholders | ||||
| -26.54M | -26.26M | -47.91M | -26.32M | -139.44K |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 819.88K | 3.86M | 6.53M | 31.86M | 130.20K |
| Total Assets | ||||
| 86.26M | 116.10M | 152.43M | 91.74M | 5.68M |
| Total Debt | ||||
| 81.74M | 86.58M | 89.62M | 15.74M | 1.67M |
| Net Debt | ||||
| 80.92M | 82.72M | 83.09M | -16.12M | 1.54M |
| Total Liabilities | ||||
| 89.68M | 100.56M | 115.26M | 37.46M | 10.10M |
| Stockholders Equity | ||||
| -3.42M | 15.54M | 37.17M | 54.28M | -4.42M |
| Cash Flow | Free Cash Flow | |||
| 8.33M | 10.57M | -8.76M | -11.45M | 441.30K |
| Operating Cash Flow | ||||
| 8.75M | 10.64M | -7.61M | -11.34M | 446.64K |
| Investing Cash Flow | ||||
| -422.35K | -1.55M | -101.37M | -37.02M | -5.35K |
| Financing Cash Flow | ||||
| -11.39M | -11.71M | 83.47M | 80.09M | -320.91K |
LifeSpeak Technical Analysis
Negative
0.20
Price Trends
0.29
Negative
0.33
Negative
0.38
Negative
Market Momentum
-0.03
Positive
38.92
Neutral
36.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LSPK, the sentiment is Negative. The current price of 0.2 is below the 20-day moving average (MA) of 0.26, below the 50-day MA of 0.29, and below the 200-day MA of 0.38, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 38.92 is Neutral, neither overbought nor oversold. The STOCH value of 36.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LSPK.
LifeSpeak Peers Comparison
Overall Rating
UnderperformOutperform
Sector (58)
Financial Indicators
Performance Comparison
TSE:LSPK
LifeSpeak
0.20
-0.43
-68.25%
TSE:KSI
kneat.com
5.99
2.22
58.89%
TSE:WELL
WELL Health Technologies Corp
3.96
0.42
11.86%
LifeSpeak Earnings Call Summary
Earnings Call Date: Mar 31, 2025 | % Change Since: -31.03% | Next Earnings Date: May 8, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture with strong partnerships and leadership appointments indicating positive developments, while financial challenges and customer retention issues suggest underlying struggles.Highlights
Consistent Revenue and Adjusted EBITDA Growth
Revenue for Q3 2024 was $11.8 million with strong adjusted EBITDA growth to $3 million, which is 26% of revenue. This represents a 17% increase compared to the second quarter of 2024.
Significant Partnership with GreenShield
LifeSpeak signed a major deal with GreenShield, a leading Canadian integrated health and benefits organization, marking one of the most significant deals in the company's history.
Strong Interest in Digital Well-being Services
Continued strong interest for LifeSpeak's whole person digital well-being services, leading to agreements with notable clients such as GreenShield, Allstate, and Asset Health.
Leadership Strengthening
Appointment of Lee Dabberdt as CFO, strengthening the senior leadership team, and enhancing the company's ability to scale business.
Geographic Diversification
67% of ARR for the quarter originated from markets outside of Canada, indicating strong international presence.
Lowlights
Revenue Decline and Headwinds
Despite consistent revenue of $11.8 million, the company faced a decline compared to previous periods and continued headwinds in the wellness software market.
Increased Net Loss
Net loss for Q3 2024 was $5.7 million, up from a net loss of $2 million in Q3 2023, largely due to financing expenses.
Decreased Net Dollar Retention and Logo Retention Rates
Net dollar retention (NDR) rate for Q3 2024 was 82%, down 6% from Q3 2023. Logo retention rate was 73%, 8% lower than in the same quarter last year.
Churn and Budgetary Constraints
Continued churn, particularly among smaller clients, driven by budgetary constraints and macroeconomic factors.
Company Guidance
During the LifeSpeak Q3 2024 earnings call, the company highlighted several key financial metrics and strategic developments. The third quarter revenue was reported at $11.8 million, with an adjusted EBITDA of $3 million, representing 26% of revenue. Despite a decline in revenue, this marked a 17% increase in adjusted EBITDA compared to the previous quarter, as LifeSpeak focused on operational efficiencies. The company's annual recurring revenue (ARR) was $45.9 million, with 67% originating from markets outside of Canada. Net loss for the quarter was $5.7 million, largely due to financing expenses. The net dollar retention rate was noted at 82%, while the logo retention rate stood at 73%. LifeSpeak also highlighted significant partnerships, including a major deal with GreenShield, and discussed ongoing efforts to mitigate client churn and pursue larger, high-margin opportunities as part of their growth strategy. Looking ahead, the company anticipates fourth-quarter results to be consistent with Q3, with growth expected to pick up in early 2025.LifeSpeak Corporate Events
Business Operations and StrategyFinancial Disclosures
LifeSpeak Inc. Reports Fiscal 2024 Results Amid Economic Challenges
Neutral
Mar 31, 2025
LifeSpeak Inc. reported its fiscal 2024 results, highlighting a revenue of $48.4 million and an Adjusted EBITDA of $11.5 million, despite facing economic challenges. The company experienced a 9% decline in fourth-quarter revenue and a 12% decrease in annual recurring revenue compared to the previous year. Despite these declines, LifeSpeak’s Adjusted EBITDA increased due to an optimized cost structure. The company is actively negotiating with lenders to address defaults on credit agreements, while notable client acquisitions and a significant agreement with GreenShield are expected to contribute positively to its business.
Delistings and Listing ChangesPrivate Placements and Financing
LifeSpeak Faces TSX Delisting Review and Credit Agreement Challenges
Negative
Mar 17, 2025
LifeSpeak Inc. announced that the Toronto Stock Exchange has deferred its decision on the company’s delisting review until April 14, 2025, following the company’s use of TSX rules related to financial difficulty for a private placement in March 2024. Additionally, LifeSpeak is in default under its senior credit agreement, which has led to a cross-default with its junior lender. The company is actively negotiating with its lenders to address these defaults and is committed to maintaining constructive relationships with them.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.